[1]
2025. Cost-Effectiveness Analysis of Two or Three Dosage Forms of N-Acetylcysteine in ICU Patients with Pneumonia. JURNAL FARMASIMED (JFM). 8, 1 (Nov. 2025), 166–172. DOI:https://doi.org/10.35451/s13m6d29.